Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?

Post time 2 hour(s) ago

journal：Journal of Pharmaceutical Sciences

Authors：Sharad B. Murdande; Michael J. Pikal; Ravi M. Shanker; Robin H. Bogner

Published date：2011-10-

DOI：10.1002/jps.22643

PDF link：https://www.sciencedirect.com/sc ... 022354915319201/pdf

Article link：https://doi.org/10.1002/jps.22643

Article Source：Elsevier BV。

Remark：

Post time 2 hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Wiley] Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable? Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?